ID: ALA4783416

Max Phase: Preclinical

Molecular Formula: C22H38N5O7P

Molecular Weight: 515.55

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCOP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C22H38N5O7P/c1-2-3-4-5-6-7-8-9-10-11-12-32-35(30,31)33-13-16-18(28)19(29)22(34-16)27-15-26-17-20(23)24-14-25-21(17)27/h14-16,18-19,22,28-29H,2-13H2,1H3,(H,30,31)(H2,23,24,25)/t16-,18-,19-,22-/m1/s1

Standard InChI Key:  OBZUJPUJZTVJCO-WGQQHEPDSA-N

Associated Targets(non-human)

Long-chain-fatty-acid--AMP ligase FadD32 36 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 515.55Molecular Weight (Monoisotopic): 515.2509AlogP: 3.08#Rotatable Bonds: 16
Polar Surface Area: 175.07Molecular Species: ACIDHBA: 11HBD: 4
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 1.91CX Basic pKa: 3.94CX LogP: 1.03CX LogD: 0.67
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.19Np Likeness Score: 1.02

References

1. Baran M,Grimes KD,Sibbald PA,Fu P,Boshoff HIM,Wilson DJ,Aldrich CC.  (2020)  Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.,  201  [PMID:32574901] [10.1016/j.ejmech.2020.112408]

Source